Elon Musk claims Tesla's unsupervised Full Self-Driving will reach widespread deployment across the US by year-end, he stated during a virtual appearance at the Smart Mobility Summit in Tel Aviv. The promise arrives as Tesla operates fewer than 30 unsupervised robotaxis across three Texas cities, a modest footprint for a system positioned as transformative technology.
This announcement continues a pattern spanning over a decade. Musk has repeatedly forecast imminent autonomous breakthroughs only to miss self-imposed deadlines. Tesla's FSD remains in limited beta testing despite years of promises about full autonomy arriving imminently. The company charges customers between $8,000 and $12,000 for FSD access, yet the system still requires driver attention and intervention. Tesla has not achieved true level 5 autonomous capability, which operates without human supervision or intervention in all conditions.
The gap between Musk's projections and Tesla's actual progress fuels skepticism across the industry and among investors. Competitors including Waymo, Cruise, and traditional automakers have taken more measured approaches to autonomous vehicle deployment, focusing on geofenced operations in specific cities rather than nationwide rollout claims.
Regulators have grown cautious about unsupervised autonomous vehicles after safety incidents involving Tesla vehicles using Autopilot and FSD beta features. NHTSA investigations into Tesla crashes involving these systems continue. Other manufacturers have demonstrated viable robotaxi operations in limited markets, but scaling to nationwide availability presents engineering, regulatory, and liability challenges Tesla has not overcome.
The timing of Musk's latest announcement matters little without execution. Tesla would need regulatory approval, substantial fleet expansion, software maturation, and real-world validation across diverse driving conditions to meet his deadline. Current evidence suggests Tesla remains years away from the widespread unsupervised autonomous deployment Musk describes.